Potential mechanism of the Shunaoxin pill for preventing cognitive impairment in type 2 diabetes mellitus.
Frontiers in neurology(2022)
摘要
Active ingredients of the Shunaoxin pill may alleviate cognitive impairment in diabetic patients by targeting the proteins OPRK1, GABRA5, GABRP, and SCN3B.
更多查看译文
关键词
Shunaoxin pill,cognitive impairment,diabetes,molecular docking,network pharmacology
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要